TY - JOUR JF - Heart JO - Heart SP - 264 LP - 264 DO - 10.1136/hrt.2010.216820 VL - 97 IS - 3 AU - Timothy D Warner Y1 - 2011/02/01 UR - http://heart.bmj.com/content/97/3/264.abstract N2 - The Authors' reply In his letter1 referring to our Viewpoint article2 Dr Cattaneo argues that aspirin is not superfluous as an antithrombotic in the presence of strong P2Y12 receptor blockers, and probably provides additional benefit. At the same time it would seem that there is some common ground between us, as he also agrees that the most … ER -